Literature DB >> 7995181

Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.

A P Weston1, D R Campbell, D H McGregor, R Cherian.   

Abstract

Gastric pseudolymphoma is a rare disorder of unknown etiology that can undergo transformation into malignant lymphoma. This report describes the first case of a gastric pseudolymphoma associated with Helicobacter pylori infection that underwent complete clinical, endoscopic, and histologic resolution following treatment with bismuth subsalicylate, amoxicillin, and metronidazole. The eradication of Helicobacter pylori may have eliminated ongoing antigenic stimulation that has previously been postulated to be responsible for the development and subsequent progression of gastric pseudolymphoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995181     DOI: 10.1007/BF02087692

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Gastric pseudolymphoma. Not necessarily a benign lesion.

Authors:  J F Sweeney; C Muus; P P McKeown; A S Rosemurgy
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Away with leniency toward gastric pseudolymphoma.

Authors:  A Sternberg; A Koren; A Kadish; J Sandbank; R Reiss
Journal:  Arch Surg       Date:  1989-06

4.  Diagnosis gastric pseudolymphoma by gastroscopic biopsy.

Authors:  A Sternberg
Journal:  Gastrointest Endosc       Date:  1987-10       Impact factor: 9.427

5.  Pseudolymphoma of the stomach.

Authors:  C J Wright
Journal:  Hum Pathol       Date:  1973-09       Impact factor: 3.466

Review 6.  Helicobacter pylori: controversies and an approach to management.

Authors:  J E Ormand; N J Talley
Journal:  Mayo Clin Proc       Date:  1990-03       Impact factor: 7.616

7.  Gastric pseudolymphoma. A challenging clinical problem.

Authors:  R K Orr; J R Lininger; W Lawrence
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

8.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Pseudolymphoma of the stomach. A clinicopathologic study of 15 cases.

Authors:  O Tokunaga; T Watanabe; M Morimatsu
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

10.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

View more
  1 in total

Review 1.  Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature.

Authors:  Toshihide Okada; Hiroshi Mibayashi; Kenkei Hasatani; Yoshiaki Hayashi; Shigetsugu Tsuji; Yoshibumi Kaneko; Masashi Yoshimitsu; Takashi Tani; Yoh Zen; Masakazu Yamagishi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.